Neuronal nicotinic acetylcholine (cholinergic) receptors (nAChRs) are expressed throughout the brain as well as in the autonomic ganglia. Starting in the mid-1980's multiple neuronal nAChR subunit genes have been identified, cloned and sequenced. Today, we know of a minimum of 11 different subunits that are expressed in mammals, and 9 of these subunits are expressed in the mouse brain. It is believed that neuronal nAChRs are pentameric ligand-gated ion channels that are similar to the well-characterized muscle-type nAChR. Tremendous progress has been made in understanding these receptors using expression systems. For example, studies done in Xenopus oocytes and cell lines indicate that altering the subunit composition of the nAChRs results in tremendous changes in the physiological and pharmacological properties of these receptors. Less is known about the naturally occurring receptors. Questions that are of current interest include: Where are the nAChRs expressed in the brain; What is the subunit composition of the brain nAChRs; What role do these receptors play in synaptic transmission; What role do they play in modulating brain function (behavior), and What is their role in modulating components of the nicotine addiction process? One tool that shows incredible promise for answering these questions is the null mutant and knockin mouse. Over the last few years nAChR subunit null mutants and knockin mice have been made in several laboratories. We have been given many of these mutant animals and more have been promised to us. These animals will be used in several funded research projects. This P30 grant has been submitted to provide support for what is the world's most complete collection of nAChR transgenic mice. Support will allow us to do studies that would otherwise be nearly impossible (given the financial support currently available) such as breeding the mice on multiple genetic backgrounds and breeding double mutants. We hope that this resource will, ultimately, be made available to other researchers in the nAChR field.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Center Core Grants (P30)
Project #
5P30DA015663-05
Application #
7172646
Study Section
Special Emphasis Panel (ZDA1-RXL-E (23))
Program Officer
Pollock, Jonathan D
Project Start
2003-05-01
Project End
2009-01-31
Budget Start
2007-02-01
Budget End
2009-01-31
Support Year
5
Fiscal Year
2007
Total Cost
$282,151
Indirect Cost
Name
University of Colorado at Boulder
Department
Type
DUNS #
007431505
City
Boulder
State
CO
Country
United States
Zip Code
80309
Moretti, Milena; Fasoli, Francesca; Gotti, Cecilia et al. (2018) Reduced ?4 subunit expression in ?4+- and ?4+- /?2+- nicotinic acetylcholine receptors alters ?4?2 subtype up-regulation following chronic nicotine treatment. Br J Pharmacol 175:1944-1956
Spindle, Michael S; Parsa, Pirooz V; Bowles, Spencer G et al. (2018) A dominant role for the beta 4 nicotinic receptor subunit in nicotinic modulation of glomerular microcircuits in the mouse olfactory bulb. J Neurophysiol 120:2036-2048
Kamens, Helen M; Silva, Constanza; McCarthy, Riley et al. (2017) No evidence of a role of the ?4 subunit of the nicotinic acetylcholine receptor in alcohol-related behaviors. BMC Res Notes 10:151
Koukouli, Fani; Rooy, Marie; Tziotis, Dimitrios et al. (2017) Nicotine reverses hypofrontality in animal models of addiction and schizophrenia. Nat Med 23:347-354
Wall, Teagan R; Henderson, Brandon J; Voren, George et al. (2017) TC299423, a Novel Agonist for Nicotinic Acetylcholine Receptors. Front Pharmacol 8:641
McClure-Begley, Tristan D; Esterlis, Irina; Stone, Kathryn L et al. (2016) Evaluation of the Nicotinic Acetylcholine Receptor-Associated Proteome at Baseline and Following Nicotine Exposure in Human and Mouse Cortex. eNeuro 3:
Pistillo, Francesco; Fasoli, Francesca; Moretti, Milena et al. (2016) Chronic nicotine and withdrawal affect glutamatergic but not nicotinic receptor expression in the mesocorticolimbic pathway in a region-specific manner. Pharmacol Res 103:167-76
Fasoli, F; Moretti, M; Zoli, M et al. (2016) In vivo chronic nicotine exposure differentially and reversibly affects upregulation and stoichiometry of ?4?2 nicotinic receptors in cortex and thalamus. Neuropharmacology 108:324-31
Marks, Michael J; O'Neill, Heidi C; Wynalda-Camozzi, Kelly M et al. (2015) Chronic treatment with varenicline changes expression of four nAChR binding sites in mice. Neuropharmacology 99:142-55
Stevens, Karen E; Zheng, Lijun; Floyd, Kirsten L et al. (2015) Maximizing the effect of an ?7 nicotinic receptor PAM in a mouse model of schizophrenia-like sensory inhibition deficits. Brain Res 1611:8-17

Showing the most recent 10 out of 86 publications